While in GBM, we found that the increased ADAMTSL4 expression but not mutation is an independent prognostic indicator, for we had not observed the mutation of ADAMTSL4 in GBMs from the TCGA dataset (data not shown). This evidence concerns the gene ADAMTSL4 and glioblastoma.